Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 2,445.00
+89.00 (3.78%)
Oct 9, 2026, 4:59 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 146.1 billion as of October 9, 2026. It is the 1,102nd most valuable company in the world and the 8th biggest in Denmark. Its market cap has increased by 13.02% in one year.
Market Cap
146.10B
Enterprise Value
170.72B
Revenue
27.03B
Global Rank
Country Rank
#8 Denmark
PE Ratio
29.53
ChartMarket Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 146.10B, an increase of 3,865.55%. That is a compound annual growth rate of 15.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 146.10B | 17.01% |
| Dec 30, 2025 | 124.86B | 31.70% |
| Dec 30, 2024 | 94.81B | -32.65% |
| Dec 29, 2023 | 140.77B | -26.77% |
| Dec 30, 2022 | 192.23B | 11.72% |
| Dec 30, 2021 | 172.06B | 6.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.13T |
| Coloplast | 98.15B |
| Demant | 71.96B |
| ALK-Abelló | 50.46B |
| H. Lundbeck | 45.13B |
| Ambu A/S | 19.02B |
| Bavarian Nordic | 17.93B |
| Zealand Pharma | 16.21B |